Randomized, double blind, placebo-controlled trial of fish-oil-based lipid emulsion infusion for treatment of critically ill patients with severe sepsis

Asian Journal of Surgery

Volumn 34, Issue 1, 2011, Pages 1-10

  Khor, Boon Siang ^a,b   Liaw, Shiumn Jen ^a   Shih, Hsin Chin ^b,c   Wang, Liang Shun ^b,d  

^a Landseed Hospital   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

clinical assessment; fish oil based lipid emulsion; severe sepsis

Indexed keywords

FISH OIL; LIPID EMULSION; OMEGA 3 FATTY ACID;

ADULT; AGED; APACHE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; APACHE; DOUBLE-BLIND METHOD; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; SEPSIS; TAIWAN;

EID: 79955394406     PISSN: 10159584     EISSN: 02193108     Source Type: Journal    
DOI: 10.1016/S1015-9584(11)60011-0     Document Type: Article

References (26)

1. C Alberti, Brun-Buisson C, Burchardi H Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study Intensive Care Med 28 2002 108 121 (Pubitemid 34293822)
2. Brun-Buisson C, Doyon F, Carlet J Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274 1995 968 974
3. RP Dellinger, MM Levy, JM Carlet Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
4. JL Breslow N-3 fatty acids and cardiovascular disease Am J Clin Nutr 83 2006 1477S 1482S (Pubitemid 44713088)
5. AP Simopoulos Omega-3 fatty acids in inflammation and autoimmune diseases J Am Coll Natr 21 2002 495 505 (Pubitemid 36026261)
6. P Mayser, K Mayer, M Mahloudjian A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acidbased lipid infusion in atopic dermatitis J Parenter Entered Nutr 26 2002 151 158 (Pubitemid 34429478)
7. AR Heller, Rössler S, Litz RJ Omega-3 fatty acids improve the diagnosis-related clinical outcome Crit Care Med 34 2006 972 979
8. MW Wichmann, P Thul, HD Czametzki Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial Crit Care Med 35 2007 700 706 (Pubitemid 46407781)
9. M Thusgaard, Christensen JH, Mørn B Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebocontrolled study Scand J Infect Dis 41 2009 760 766
10. GJ Wanten, PC Calder Immune modulation by parenteral lipid emulsions Am J Clin Nutr 85 2007 1171 1184 (Pubitemid 46740457)
11. K Mayer Fish oil in critical illness Curr Opin Clin Nurt Metab Care 11 2008 121 127 (Pubitemid 351323172)
12. RC Bone, RA Balk, FB Cerra Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1992 1644 1655
13. MM Levy, MP Fink, JC Marshall 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 2003 1250 1256 (Pubitemid 36444440)
14. WA Knaus, EA Draper, DP Wagner APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829 (Pubitemid 15250137)
15. WA Knaus, DP Wagner, EA Draper The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults Chest 100 1991 1619 1636
16. JR Le Gall, Lemeshow S, Saulnier F A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study JAMA 270 1993 2957 2963
17. K Mayer, S Gokorsch, C Fegbeutel Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis Am J Respir Crit Care Med 167 2003 1321 1328 (Pubitemid 36609714)
18. B Afessa, O Gajic, MT Keegan Severity of illness and organ failure assessment in adult intensive care units Crit Care Clin 23 2007 639 658 (Pubitemid 47449737)
19. I Kelbel, T Koch, A Prechtl Effects of parenteral application of fish oil versus soy oil emulsions on bacterial clearance functions Infasionsther Transfasionsmed 26 1999 226 232 (Pubitemid 29370457)
20. E Pscheidl, M Schywalsky, K Tschaikowsky Fish oilsupplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model Crit Care Med 28 2000 1489 1496 (Pubitemid 30324529)
21. C Balcl, H Sungurtekin, Gürses E Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit Crit Care 7 2003 85 90 (Pubitemid 36204274)
22. M Hatzistilianou Diagnostic and prognostic role of procalcitonin in infections Scientific World J 10 2010 1941 1946
23. P Singer, H Shapiro, M Theilla Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective Intensive Care Med 34 2008 1580 1592
24. ER Pacht, DeMichele SJ, Nelson JL Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome Crit Care Med 31 2003 491 500 (Pubitemid 36232946)
25. MR Pinsky, JL Vincent, J Deviere Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality Chest 103 1993 565 575 (Pubitemid 23070764)
26. K Mayer, S Meyer, Reinholz-Muhly M Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans J Immunol 171 2003 4837 4843 (Pubitemid 37310605)